Chem. J. Chinese Universities ›› 2021, Vol. 42 ›› Issue (11): 3421.doi: 10.7503/cjcu20210455

• Review • Previous Articles     Next Articles

Research Progress of Multiplex Immunoassay

LUO Cheng1, PENG Yamei1, SHEN Hong1, FANG Qun1,2, PAN Jianzhang1,2()   

  1. 1.Department of Chemistry,Zhejiang University,Hangzhou 310058,China
    2.Hangzhou Global Scientific and Technological Innovation Center,Zhejiang University,Hangzhou 311200,China
  • Received:2021-06-30 Online:2021-11-10 Published:2021-11-10
  • Contact: PAN Jianzhang E-mail:kelvonpan@zju.edu.cn
  • Supported by:
    the National Natural Science Foundation of China(21974122);the Natural Science Foundation of Zhejiang Province, China(LY19B050002)

Abstract:

Clinically, immunoassay is the main method to detect physiologically related protein indicators. Compared with the singleplex immunoassay, clinical in vitro diagnosis has a greater demand for the multiplex immunoassay of physiologically related proteins. The heterogeneous immunoassay method that complete the immune reaction on a solid-phase carrier has the advantage of high sensitivity, and has become the main method of multiplex immunoassay at present. According to the different solid-phase, the research progress of multiplex immunoassay systems in recent years has been reviewed in terms of technical principles, methods, and characteristics. Finally, the advantages and disadvantages of different systems are compared and summarized, and the development of microfluidic multiplex immunoassay in the point of caring testing(POCT) field is prospected.

Key words: Immunoassay, Multiplex, Microfluidic, Point of caring testing(POCT)

CLC Number: 

TrendMD: